← Back
$ELVN All transactions

Enliven Therapeutics, Inc.

▼ SELL

$ Value

$296K

Shares

10,000

Price

$30

Filed

Mar 10

Insider

Name

Hohl Benjamin

Title

CHIEF FINANCIAL OFFICER

CIK

0001882764

Roles

Officer

Transaction Details

Transaction Date

2026-03-06

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

51,000

Footnotes

This transaction was executed in multiple trades at prices ranging from $29.43 to $29.7867. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. | Certain of these securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock, subject to the applicable vesting schedule and conditions of each RSU.

Filing Info

Accession No.

0001882764-26-000002

Form Type

4

Issuer CIK

0001672619

Hohl Benjamin's History

Date Ticker Type Value
2026-03-06 ELVN $296K
2026-02-12 ELVN A $0
2026-02-12 ELVN A $0
2025-12-22 ELVN M $32K
2025-12-22 ELVN M $0
2025-09-29 ELVN M $8K
2025-09-29 ELVN $66K
2025-09-29 ELVN M $0
2025-08-27 ELVN M $8K
2025-08-27 ELVN $67K

Other Insiders at ELVN (90d)

Insider Bought Sold Last
Garland J. Scott 2026-02-12
Kunkel Lori Anne 2026-02-12
Gupta Rishi 2026-02-12
Heyman Richard A. $32K 2026-02-17
Bauer Jake 2026-02-12
Collins Helen Louise
CHIEF MEDICAL OFFICER
$4.2M 2026-04-17
Ballal Rahul D. 2026-02-12
Derynck Mika K 2026-02-12
Hohl Benjamin
CHIEF FINANCIAL OFFICER
2026-02-12
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
$145K 2026-02-12
Patel Anish
CHIEF OPERATING OFFICER
2026-02-12